Indefinite Delivery Contract W81K0225DA018
- Not listed
- Diasorin Inc. was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency on October 1, 2025, with a ceiling value of $540,000 and a performance period extending through September 30, 2030. The contract procures LIAISON XL test kits, supplies, and analyzer equipment without the application of any set-aside designation, reflecting competitive procurement practices. As the U.S. Department of Defense's health services organization, the Defense Health Agency utilizes this...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, for the supply of reagents, automated diagnostic testing equipment, and related services. The single-award contract has a ceiling value of $321,055.77 and a period of performance through September 30, 2025. Diasorin Inc. is a subsidiary of the parent company Diasorin S.P.A., which has an extensive track record as a federal contractor,...
- Diasorin Inc., a foreign-owned medical diagnostics subsidiary of Italian-based Diasorin S.P.A., was awarded a General Services Administration Multiple Award Schedule contract valued at $2.8 million on November 9, 2020, with an ultimate completion date of November 8, 2030. This civilian agency contract, administered through the Federal Acquisition Service, procures advanced chemiluminescence immunoassay analyzers and related diagnostic equipment, primarily the LIAISON XL and LIAISON XS analyzer...
- This Indefinite Delivery Contract was awarded by the Veterans Integrated Service Network 17 (VISN 17), a component of the Department of Veterans Affairs, to Diasorin Inc., a foreign-owned medical diagnostics company headquartered in Stillwater, Minnesota. The single-award contract, valued at $291,245.30 with a performance period extending through July 14, 2026, was awarded on July 24, 2024, without set-aside designation. The contract establishes a vehicle for the procurement of AMA DIASORIN...
- This federal contract IDV award was issued by the Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, with Diasorin S.P.A. as the parent company. The single-award, firm-fixed-price indefinite-delivery/indefinite-quantity (IDIQ) contract, valued at $1,754,335.20, is for the lease of Liaison XL analyzers, installation, training, preventative maintenance, services/repairs, and associated reagents, consumables, and supplies for VA medical...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite-delivery, indefinite-quantity contract to Diasorin Inc. to provide diagnostic testing services and related equipment. The contract has a potential value of $2,000,000 and period of performance from October 1, 2021 through September 30, 2026. Delivery orders issued against the contract include diagnostic testing for procalcitonin, vitamin D, tuberculosis, and COVID-19...
- The federal contract IDV award to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, is a $10 million Federal Supply Schedule (FSS) contract from the Department of Veterans Affairs (VA). The contract, with a period of performance through March 2030, is for the provision of cost-per-test clinical laboratory analyzers and associated services. Diasorin Inc. is the prime contractor, with its parent company Diasorin S.P.A. providing overall corporate support. The contract provides...
- Diasorin Molecular, LLC has been awarded a single-award Indefinite Delivery Contract with a ceiling value of $300,000 by Veterans Integrated Service Network 10 (VISN 10), a civilian division of the Department of Veterans Affairs, effective from December 1, 2025, through November 30, 2030. The contract procures the DiaSorin Liaison MDX Candida auris screening diagnostic solution, an automated real-time polymerase chain reaction (PCR) thermocycler system designed for rapid identification of...
- Diasorin Inc. has been awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Integrated Service Network 15 (VISN 15) with a ceiling value of $730,616.95 and a performance period extending from January 5, 2026 through January 4, 2031. The contract procures a fully automated chemiluminescence analyzer system, specifically a LIAISON XL analyzer, along with all associated reagents, standards, controls, supplies, and disposables required to support...
- This indefinite delivery contract was awarded by the Defense Health Agency (DHA), a defense agency, to Diasorin Deutschland GMBH, a foreign-owned, for-profit manufacturer of medical products. The contract has a ceiling value of $732,571.15 and a period of performance through September 4, 2028. It is a single-award contract that does not utilize any set-asides. The contract is for the provision of medical testing supplies and laboratory equipment, specifically the RPP NXTAG (IVD-US) 96 test kits,...
- W81K0225DA018Indefinite Delivery Contract
- 1Federal Contract Awards
The Defense Health Agency awarded a single-award Indefinite Delivery Contract valued at $308,010 to Diasorin Inc. (UEI: FGK2QR959BV5), a Minnesota-based subsidiary of Italian medical diagnostics firm Diasorin S.P.A., effective October 1, 2025, through September 30, 2030. This five-year contract establishes a procurement vehicle for LIAISON MDX diagnostic test kits and supplies to support the Department of Pathology and Microbiology at Madigan Healthcare System, Joint Base Lewis-McChord (JBLM). The contract was awarded competitively without set-aside designation, reflecting Diasorin's established capability to provide specialized diagnostic solutions to federal healthcare networks. As a key supplier of chemiluminescence immunoassay analyzers, reagents, and consumables, Diasorin leverages its LIAISON product line to deliver comprehensive infectious disease and immunochemistry testing capabilities across the Defense Health Agency's medical infrastructure. The associated delivery order, valued at $61,602 and awarded concurrently on October 1, 2025, specifies LIAISON MDX supply kit procurement with performance in Tacoma, Washington, under firm fixed-price terms and a completion date of September 30, 2026. This delivery order represents the initial task order under the indefinite delivery vehicle and demonstrates the contract's application to direct federal healthcare facility operations. The LIAISON MDX analyzer platform supports critical diagnostic testing requirements including COVID-19, tuberculosis, cytomegalovirus, varicella, and other infectious disease diagnostics essential to military medical readiness. Diasorin's extensive track record with the Department of Veterans Affairs, Centers for Disease Control and Prevention, and other federal agencies, combined with its technical expertise in automated immunoassay systems, positions the company to fulfill this five-year procurement requirement for Madigan Healthcare System's laboratory operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/18/25 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order W81K0225DA018-W81K0225FA138 | Diasorin Inc. | $61.6k | 10/1/25 | 9/30/26 | 9/18/25 |